Similar articles for PMID: 15758009

Year	Number of Results
1991	1
2001	2
2002	4
2003	3
2004	2
2005	8
2006	9
2007	9
2008	15
2009	30
2010	33
2011	26
2012	24
2013	32
2014	30
2015	9
2016	3
2017	8
2018	8
2019	2
2020	11
2021	22
2022	27
2023	11
2024	0

1

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. N Engl J Med. 2005. PMID: 15758009 Free article. Clinical Trial.

2

Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.

Erpolat OP, Akmansu M, Goksel F, Bora H, Yaman E, Büyükberber S. Erpolat OP, et al. Tumori. 2009 Mar-Apr;95(2):191-7. doi: 10.1177/030089160909500210. Tumori. 2009. PMID: 19579865

3

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes AA, Hilton M, Abrey L, Cloughesy T. Chinot OL, et al. N Engl J Med. 2014 Feb 20;370(8):709-22. doi: 10.1056/NEJMoa1308345. N Engl J Med. 2014. PMID: 24552318 Free article. Clinical Trial.

4

Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma.

Muni R, Minniti G, Lanzetta G, Caporello P, Frati A, Enrici MM, Marchetti P, Enrici RM. Muni R, et al. Tumori. 2010 Jan-Feb;96(1):60-4. doi: 10.1177/030089161009600110. Tumori. 2010. PMID: 20437859 Clinical Trial.

5

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G, Tombolini V, Maurizi Enrici R. Minniti G, et al. J Neurooncol. 2008 May;88(1):97-103. doi: 10.1007/s11060-008-9538-0. Epub 2008 Feb 5. J Neurooncol. 2008. PMID: 18250965

6

Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.

Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R. Donato V, et al. Tumori. 2007 May-Jun;93(3):248-56. doi: 10.1177/030089160709300304. Tumori. 2007. PMID: 17679459

7

Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.

Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam DH. Jeon HJ, et al. Clin Neurol Neurosurg. 2009 Oct;111(8):679-82. doi: 10.1016/j.clineuro.2009.06.013. Epub 2009 Jul 28. Clin Neurol Neurosurg. 2009. PMID: 19640635 Clinical Trial.

8

Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience.

Jalali R, Basu A, Gupta T, Munshi A, Menon H, Sarin R, Goel A. Jalali R, et al. Br J Neurosurg. 2007 Dec;21(6):583-7. doi: 10.1080/02688690701604574. Br J Neurosurg. 2007. PMID: 18071985

9

Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.

Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A. Lanzetta G, et al. Anticancer Res. 2003 Nov-Dec;23(6D):5159-64. Anticancer Res. 2003. PMID: 14981983 Clinical Trial.

10

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Stupp R, et al. Lancet Oncol. 2009 May;10(5):459-66. doi: 10.1016/S1470-2045(09)70025-7. Epub 2009 Mar 9. Lancet Oncol. 2009. PMID: 19269895 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

282 results

Results by year